The purpose of this study was to analyze the criterion‐related validity and the reliability of the standing long jump test (SLJ) for evaluating the lower‐body explosive muscular strength in adults. A total of 410 adults participated in this study. Sociodemographic, anthropometric measurements, laboratory lower‐body muscular strength tests, and the field‐based SLJ were performed. In validity analysis, stepwise regression analysis showed that maximal horizontal power, sex, percentage of body fat, maximal horizontal force, and lean mass were significantly associated with the SLJ distance (R² = 0.78; p < 0.001). Reliability analysis showed significant differences between test–retest in the SLJ test, with an overestimation of the second measurement compared to the first [12.14 ± 14.46 cm, intraclass correlation coefficient (ICC) = 0.94 (0.75–0.97), p < 0.001; Cohen's d = 0.31]. The coefficient of variation (CV) was 7.06% and the minimal detectable change (MDC₉₀) was 29 cm. After a learning period, higher reliability values were found [0.45 ± 1.04 cm, ICC = 1.00 (0.99–1.00); p = 0.001; CV = 0.53 %; MDC₉₀ = 1 cm]. The SLJ test may be a valid tool to assess lower‐body explosive muscular strength in the adult population. A learning period may be necessary to provide reliability on the SLJ test.

Motor fitness and flexibility have been linked to several health issues. We aimed to investigate the predictive validity of motor fitness and flexibility tests in relation to health outcomes in adults and older adults. Web of Science and PubMed databases were screened for studies published from inception to November 2020. Two authors systematically searched, evaluated, and extracted data from identified original studies and systematic reviews/meta-analysis. Three levels of evidence were constructed: strong, moderate, and limited/inconclusive evidence. In total, 1182 studies were identified, and 70 studies and 6 systematic reviews/meta-analysis were summarized. Strong evidence indicated that (i) slower gait speed predicts falls and institutionalization/hospitalization in adults over 60 years old, cognitive decline/impairment over 55 years old, mobility disability over 50 years old, disability in instrumental activities of daily living (IADL) over 54 years old, cardiovascular disease risk over 45 years old, and all-cause mortality over 35 years old; (ii) impaired balance predicts falls and disability in IADL/mobility disability in adults over 40 years old and all-cause mortality over 53 years old; (iii) worse timed up&go test (TUG) predicts falls and fear of falling over 40 years old. Evidence supports that slower gait speed, impaired balance, and worse TUG performance are significantly associated with an increased risk of adverse health outcomes in adults.

There is controversy about the relationship between ACE I/D polymorphism and health. Seventy-four healthy adults (n = 28 women; 22.5 ± 4.2 years) participated in this cross-sectional study aimed at determining the influence of ACE I/D polymorphism, ascertained by polymerase chain reaction, on cardiometabolic risk (i.e., waist circumference, body fat, blood pressure (BP), glucose, triglycerides, and inflammatory markers), maximal fat oxidation (MFO), cardiorespiratory fitness (maximal oxygen uptake), physical activity and diet. Our results showed differences by ACE I/D polymorphism in systolic BP (DD: 116.4 ± 11.8 mmHg; ID: 116.7 ± 6.3 mmHg; II: 109.4 ± 12.3 mmHg, p = 0.035) and body fat (DD: 27.3 ± 10.8%; ID: 22.6 ± 9.7%; II: 19.3 ± 7.1%, p = 0.030). Interestingly, a genotype*sex interaction in relativized MFO by lean mass (p = 0.048) was found. The DD polymorphism had higher MFO values than ID/II polymorphisms in men (8.4 ± 3.0 vs. 6.5 ± 2.9 mg/kg/min), while the ID/II polymorphisms showed higher R-MFO values than DD polymorphism in women (6.6 ± 2.3 vs. 7.6 ± 2.6 mg/kg/min). In conclusion, ACE I/D polymorphism is apparently associated with adiposity and BP, where a protective effect can be attributed to the II genotype, but not with cardiorespiratory fitness, diet and physical activity. Moreover, our study highlighted that there is a sexual dimorphism in the influence of ACE I/D gene polymorphism on MFO.